Does raloxifene reduce postmenopausal women's risk of breast cancer?
- PMID: 10660790
- PMCID: PMC1987633
Does raloxifene reduce postmenopausal women's risk of breast cancer?
Similar articles
-
Raloxifene and its role in breast cancer prevention.Expert Rev Anticancer Ther. 2004 Aug;4(4):523-32. doi: 10.1586/14737140.4.4.523. Expert Rev Anticancer Ther. 2004. PMID: 15270657 Review.
-
Does raloxifene reduce breast cancer risk?J Fam Pract. 1999 Sep;48(9):659-60. J Fam Pract. 1999. PMID: 10498063 No abstract available.
-
Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.Maturitas. 2008 Jun 20;60(2):92-107. doi: 10.1016/j.maturitas.2008.04.009. Epub 2008 Jun 4. Maturitas. 2008. PMID: 18534794 Review.
-
Raloxifene: bone and cardiovascular effects.J Endocrinol Invest. 2005;28(10 Suppl):85-9. J Endocrinol Invest. 2005. PMID: 16550730 Review.
-
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.Menopause. 2003 Jul-Aug;10(4):337-44. doi: 10.1097/01.GME.0000058772.59606.2A. Menopause. 2003. PMID: 12851517 Clinical Trial.
Cited by
-
Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?Can Fam Physician. 2001 Oct;47:1982-4. Can Fam Physician. 2001. PMID: 11723592 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical